Accuray Company Profile

00:55 EDT 21st June 2018 | BioPortfolio

Accuray's history began when John R. Adler, MD, professor of neurosurgery and radiation oncology at Stanford University Medical Center, developed the CyberKnife® System in 1987 after completing a fellowship in Sweden with Lars Leksell, MD, the founder of radiosurgery. With the CyberKnife System, Adler’s vision was to develop a non-invasive robotic radiosurgery system with superior accuracy for treatment of tumors anywhere in the body. The revolutionary concept reached far beyond the practice of radiosurgery at the time, which restricted radiosurgery to the treatment of intracranial tumors. After his initial work developing the CyberKnife System, Adler together with a group from Stanford and a manufacturer of linac technology teamed up and founded Accuray, Inc. in 1990. FDA-cleared for the treatment of head, neck and upper spine tumors in 1999, the CyberKnife was the first and only radiosurgery system to combine image guidance and computer controlled robotics giving birth to the next generation in radiosurgery – intelligent robotic radiosurgery.


1310 Chesapeake Terrace
United States of America


Phone: 1-408-716-4600
Fax: 1-408-716-4601

News Articles [16 Associated News Articles listed on BioPortfolio]

Quotidian Technical Highlights on Selected Medical Equipment Stocks -- Accuray, K2M Group, ... Accuray On Wednesday, shares in Sunnyvale, Californiaheadquartered Accuray Inc. recorded a trading volume of 1.56 million shares, which was above their three mo...

Study shows positive results for Accuray's CyberKnife system

A 138-patient study in the journal Neurosurgery found the use of Accuray's CyberKnife system in stereotactic radiosurgery pro -More- 

A Spark At Accuray - Will It Catch Fire This Time?

Accuray Moves Back From A Spark To A Damp Squib

Accuray (ARAY) Presents At RBC Capital Markets Global Healthcare Conference - Slideshow

Accuray's (ARAY) CEO Josh Levine on Q3 2018 Results - Earnings Call Transcript

Accuray's (ARAY) CEO Joshua Levine on Q2 2018 Results - Earnings Call Transcript

Accuray Retires February 2018 Convertible Notes

"We have enhanced our capital structure by significantly reducing our convertible note exposure over the last several years while minimizing shareholder dilution," said Kevin Waters, Chief Read m...

Drugs and Medications [0 Results]


PubMed Articles [3 Associated PubMed Articles listed on BioPortfolio]

Evaluation of the accuracy of the CyberKnife Synchrony Respiratory Tracking System using a plastic scintillator.

The Synchrony Respiratory Tracking System of the CyberKnife Robotic Radiosurgery System (Accuray, Inc., Sunnyvale CA) enables real-time tracking of moving targets such as lung and liver tumors during ...

Cyberknife stereotactic radiosurgery and radiation therapy treatment planning system.

CyberKnife is an image-guided stereotactical dose delivery system designed for both focal irradiation and radiation therapy (SRT). Focal irradiation refers the use of many small beams to deliver highl...

Second pelvic recurrence of rectal cancer successfully treated with a re-reirradiation (3rd radiation course).

In case of pelvic recurrence of colorectal cancer, reirradiation of previously irradiated patients may increase the rate of salvage radical resection. Due to the high cumulative dose, one of the main ...

Clinical Trials [0 Results]


Companies [4 Associated Companies listed on BioPortfolio]

Accuray Incorporated

Accuray Incorporated (Nasdaq: ARAY), based in Sunnyvale, Calif., is a global leader in the field of radiosurgery dedicated to providing an improved quality of life and a non-surgical treatment option ...


Accuray's history began when John R. Adler, MD, professor of neurosurgery and radiation oncology at Stanford University Medical Center, developed the CyberKnife® System in 1987 after completing a fel...

Accuray Inc.

Speck Design

Speck Design is Silicon Valley’s leading product design firm. We specialize in industrial and mechanical design services. Speck Design develops products with highly complex r...

More Information about "Accuray" on BioPortfolio

We have published hundreds of Accuray news stories on BioPortfolio along with dozens of Accuray Clinical Trials and PubMed Articles about Accuray for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Accuray Companies in our database. You can also find out about relevant Accuray Drugs and Medications on this site too.

Quick Search


Relevant Topics

Neurology - Central Nervous System (CNS)
Alzheimer's Disease Anesthesia Anxiety Disorders Autism Bipolar Disorders Dementia Epilepsy Multiple Sclerosis (MS) Neurology Pain Parkinson's Disease Sleep Disorders Neurology is the branch of me...

  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...

Corporate Database Quicklinks

Searches Linking to this Company Record